✦ LIBER ✦

P.338 Hepatitis B vaccine induces cellular immune responses in most humoral non-responders

✍ Scribed by T. Bauer; S. Broodhaers; P. Van Damme; W. Jilg

Book ID: 117770548
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 137 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80512-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Most humoral non-responders to hepatitis

Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses

✍ L Jarrosson; M.N Kolopp-Sarda; P Aguilar; M.C Béné; M.L Lepori; M.C Vignaud; G.C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 199 KB

A novel therapeutic hepatitis B vaccine

A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice

✍ Buchmann, Pascale; Dembek, Claudia; Kuklick, Larissa; Jäger, Clemens; Tedjokusum 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 640 KB

Hepatitis B DNA vaccine induces protecti

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination

✍ Scott T Rottinghaus; Gregory A Poland; Robert M Jacobson; Lori J Barr; Mike J Ro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Failure of hepatitis B vaccination to in

Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis

✍ Manuela Merli; Giorgia Nicolini; Francesco Adolfo Attili; Daniele Accapezzato; V 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Cellular and humoral immune responses in

Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen

✍ Fareed Rahman; Anja Dahmen; Sabine Herzog-Hauff; Wulf O. Böcher; Peter R. Galle; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

The vaccination route may influence the success of immunization against pathogens. The conventional intramuscular (i.m.) application of a vaccine containing the hepatitis B virus (HBV) surface antigen (HBsAg) led to protective anti-HBs antibody levels in the majority of vaccine recipients. In this s

LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC

LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNE RESPONSES AGAINST HBsAg IN IMMUNODEFICIENT NON-RESPONDERS TO HEPATITIS B VACCINATION

✍ Meuer, StefanC.; Dumann, Hubert; Meyer Zum Büschenfelde, Karl-Hermann; Köhler, H 📂 Article 📅 1989 🏛 The Lancet 🌐 English ⚖ 624 KB